ArticleFrontiers in endocrinology2026
Gestational and postpartum maternal consequences of gestational diabetes mellitus.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Gestational diabetes mellitus (GDM) is a significant complication during pregnancy with varying prevalence across countries and ethnicities. In Taiwan, although GDM prevalence rose from 7.6% to 13.4% between 2004 and 2015, its maternal gestational and extended consequences remained underexamined. The nationwide population-based study aims to investigate GDM-related risk factors and identify the critical period during which GDM likely poses long-term health risks. Methods: A total of 206,831 adult pregnant women from the National Health Insurance Research Database were divided into GDM ( Results: The incidence of preterm labor, preeclampsia, and gestational hypertension were significantly higher in the GDM group. The odd ratios of these consequences were 1.72, 2.86, and 2.85, respectively. GDM significantly affected the development of type 2 DM, chronic kidney disease (CKD), and ophthalmic disease. The hazard ratios of these diseases were 2.88, 1.54, and 1.63, respectively. Kaplan-Meier analysis revealed that GDM significantly increased these diseases during follow-up, especially within 2 years for type 2 DM and within 1 year for CKD and ophthalmic disease after delivery. Concolusion: GDM was associated with higher risks of preterm labor, gestational hypertension, preeclampsia, type 2 DM, CKD, and ophthalmic disease. Postpartum GDM follow-up time is 2 years for type-2 DM and 1 year for CKD and ophthalmic disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.